UNKNOWN/ DE000HG8U5K2 /
15/11/2024 17:00:53 | Var.-0.170 | Denaro17:13:33 | Lettera17:13:33 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.460EUR | -26.98% | 0.460 Quantità in denaro: 40,000 |
0.470 Quantità in lettera: 40,000 |
Microchip Technology... | 59.3541 USD | 31/12/2078 | Call |
GlobeNewswire
27/08
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
21/08
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual...
GlobeNewswire
19/08
Expanded Single Pair Ethernet Portfolio with 100BASE-T1 and 1000BASE-T1 PHY Transceivers for Network...
GlobeNewswire
15/08
Microchip Technology Adds ECC20x and SHA10x Families of Secure Authentication ICs to TrustFLEX Platf...
GlobeNewswire
13/08
Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near...
GlobeNewswire
13/08
Microchip and Acacia Collaborate to Enable Optimized Terabit-Scale Data Center Interconnect Systems
GlobeNewswire
03/08
Microchip Technology to Present at the KeyBanc Capital Markets Technology Leadership Forum
GlobeNewswire
02/08
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
GlobeNewswire
01/08
Microchip Technology Announces Financial Results for First Quarter of Fiscal Year 2025
GlobeNewswire
01/08
Microchip Technology Increases Quarterly Cash Dividend 10.7% Year-Over-Year to 45.4 Cents Per Share
GlobeNewswire
30/07
Microchip Technology Introduces a New Core in the dsPIC® Digital Signal Controller Family to Enhance...
GlobeNewswire
22/07
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
GlobeNewswire
18/07
SEALSQ Mitigates Geopolitical Risks by Manufacturing Its Next-Generation Semiconductors in Singapore...
GlobeNewswire
18/07
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Co...
GlobeNewswire
18/07
Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
GlobeNewswire
15/07
Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation...
GlobeNewswire
11/07
Model N Named in U.S. News & World Report’s 2024-2025 Best Companies to Work For